These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 19019651

  • 1. Hemoglobin-based oxygen carriers as rescue therapy: justified experiment or unnecessary risk?
    Sarani B, Pryor J.
    J Clin Anesth; 2008 Nov; 20(7):489-91. PubMed ID: 19019651
    [No Abstract] [Full Text] [Related]

  • 2. Blood alternative products: correction regarding Jehovah's Witnesses.
    Muller CF.
    S Afr Med J; 2009 Feb; 99(2):72, 74; author reply 74. PubMed ID: 19422107
    [No Abstract] [Full Text] [Related]

  • 3. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia.
    Mackenzie CF, Moon-Massat PF, Shander A, Javidroozi M, Greenburg AG.
    Anesth Analg; 2010 Mar 01; 110(3):685-93. PubMed ID: 20042443
    [Abstract] [Full Text] [Related]

  • 4. Difficult to swallow: warm autoimmune hemolytic anemia in a Jehovah's Witness treated with hemoglobin concentrate complicated by achalasia.
    Epperla N, Strouse C, VanSandt AM, Foy P.
    Transfusion; 2016 Jul 01; 56(7):1801-6. PubMed ID: 27062564
    [Abstract] [Full Text] [Related]

  • 5. Management of hemorrhagic shock when blood is not an option.
    Mackenzie CF, Morrison C, Jaberi M, Genuit T, Katamuluwa S, Rodriguez A.
    J Clin Anesth; 2008 Nov 01; 20(7):538-41. PubMed ID: 19019664
    [Abstract] [Full Text] [Related]

  • 6. Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature.
    Donahue LL, Shapira I, Shander A, Kolitz J, Allen S, Greenburg G.
    Transfusion; 2010 Jul 01; 50(7):1561-7. PubMed ID: 20456679
    [Abstract] [Full Text] [Related]

  • 7. Use of the blood substitute HBOC-201 in critically ill patients during sickle crisis: a three-case series.
    Davis JM, El-Haj N, Shah NN, Schwartz G, Block M, Wall J, Tidswell M, DiNino E.
    Transfusion; 2018 Jan 01; 58(1):132-137. PubMed ID: 29076161
    [Abstract] [Full Text] [Related]

  • 8. Successful use of a polymerized hemoglobin blood substitute in a critically anemic Jehovah's Witness.
    Allison G, Feeney C.
    South Med J; 2004 Dec 01; 97(12):1257-8. PubMed ID: 15646766
    [Abstract] [Full Text] [Related]

  • 9. Jehovah's Witnesses and artificial blood.
    Muramoto O.
    CMAJ; 2001 Apr 03; 164(7):969. PubMed ID: 11314449
    [No Abstract] [Full Text] [Related]

  • 10. Long-term transfusion of polymerized bovine hemoglobin in a Jehovah's Witness following chemotherapy for myeloid leukemia: a case report.
    Agrawal YP, Freedman M, Szczepiorkowski ZM.
    Transfusion; 2005 Nov 03; 45(11):1735-8. PubMed ID: 16271098
    [Abstract] [Full Text] [Related]

  • 11. Hemoglobin-based oxygen carriers: compassionate use and compassionate clinical trials.
    Weiskopf RB.
    Anesth Analg; 2010 Mar 01; 110(3):659-62. PubMed ID: 20185643
    [No Abstract] [Full Text] [Related]

  • 12. Hemoglobin-based oxygen carriers: development and clinical potential.
    Ketcham EM, Cairns CB.
    Ann Emerg Med; 1999 Mar 01; 33(3):326-37. PubMed ID: 10036348
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.
    Ball AM, Winstead PS.
    Pharmacotherapy; 2008 Nov 01; 28(11):1383-90. PubMed ID: 18956998
    [Abstract] [Full Text] [Related]

  • 14. Artificial Oxygen Carriers: Exactly How Close Are We to an Ultimate Product?
    Simoni J.
    Artif Organs; 2017 Apr 01; 41(4):316-318. PubMed ID: 28397406
    [No Abstract] [Full Text] [Related]

  • 15. When the pregnant Jehovah's Witness patient refuses blood: implications for nurses.
    Braithwaite P, Chichester M, Reid A.
    Nurs Womens Health; 2017 Apr 01; 14(6):462-70. PubMed ID: 21122081
    [No Abstract] [Full Text] [Related]

  • 16. The administration of polymerized human hemoglobin (Pyridoxylated) to a Jehovah's Witness after submyeloablative stem cell transplantation complicated by delayed graft failure.
    Smith SE, Toor A, Rodriguez T, Stiff P.
    Compr Ther; 2006 Apr 01; 32(3):172-5. PubMed ID: 17435270
    [Abstract] [Full Text] [Related]

  • 17. Use of a blood substitute in a patient who refuses to accept a transfusion.
    Frackiewicz EJ, Lee R.
    Am J Hosp Pharm; 1991 Oct 01; 48(10):2176; discussion 2176-80. PubMed ID: 1781475
    [No Abstract] [Full Text] [Related]

  • 18. How do we treat life-threatening anemia in a Jehovah's Witness patient?
    Posluszny JA, Napolitano LM.
    Transfusion; 2014 Dec 01; 54(12):3026-34. PubMed ID: 25330835
    [Abstract] [Full Text] [Related]

  • 19. Large volume polymerized haemoglobin solution in a Jehovah's Witness following abruptio placentae.
    Cothren CC, Moore EE, Long JS, Haenel JB, Johnson JL, Ciesla DJ.
    Transfus Med; 2004 Jun 01; 14(3):241-6. PubMed ID: 15180817
    [Abstract] [Full Text] [Related]

  • 20. Human haemoglobin--Northfield. PolyHeme.
    Drugs R D; 2002 Jun 01; 3(2):121-2. PubMed ID: 12001815
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.